DALLAS, Aug. 26, 2025 /PRNewswire/ — Skytale Investment Banking (“Skytale”), an investment banking firm specializing in healthcare and consumer businesses, is pleased to announce that it acted as the sell-side advisor to Magic Science Corporation (“MSC” or the “Company”), an innovative health sciences company, on its partnership with NexPhase Capital (“NexPhase” or “NPC”), a thematically driven and operationally focused private equity firm. This investment deepens Skytale’s expansion into consumer health and beauty products, reinforcing its position as a leading investment bank.
Magic Science Corporation has received an investment from NexPhase Capital.
Established in 2023 by husband-and-wife team Justin and Chelsea Kerzner, Magic Science Corporation is revolutionizing daily care with a diverse portfolio of products supporting health and hygiene, from skincare to surface solutions, with full control over production from formulation to packaging to retail. Its leading brand, Magic Molecule, is a trusted authority in modern skin health, delivering FDA-cleared, science-backed formulations that tackle over 50 common skin concerns.
“The partnership between Magic Science Corporation and NexPhase Capital underscores MSC’s rapidly growing and highly respected brand in the skincare and household consumer goods sector,” said Miguel Mireles, Director of Investment Banking at Skytale. “We are honored to have represented Justin and Chelsea Kerzner in this significant transaction with a leading consumer and healthcare private equity firm. This growth-focused partnership reflects MSC’s dedication to their consumers, employees, and is evidence of their passion for delivering high-quality skincare and household solutions globally.”
“This partnership with NexPhase allows us to scale and spread awareness about hypochlorous acid, a fascinating molecule our white blood cells naturally produce to fight bacteria. Your body makes it. We bottled it,” said Justin Kerzner, co-founder and chief executive officer of Magic Science Corporation. “Magic Science Corporation was founded on the belief that safe, science-backed skincare and household solutions should be accessible to everyone.”
With this transaction, Skytale once again demonstrates its unmatched expertise and results-driven approach in representing founders in the next stage of their business.
Skytale Director, Miguel Mireles; Vice President, James Wimpress; and Senior Analyst, Ryan Gerteisen represented MSC in the transaction.
About Skytale Group:
Skytale Group is an investment banking and management consulting firm based in Dallas, TX. Skytale offers tailored and comprehensive strategic transaction guidance to founders and private equity firms looking to grow, scale, or sell their businesses. Skytale’s highly experienced team relies on vast knowledge of the consumer and healthcare industries they serve to guide clients in making decisions that move their businesses forward. Certain principals of Skytale Group are licensed Investment Banking agents registered with Burch & Company, Inc., 4151 N. Mulberry Dr, Ste 235, Kansas City, MO 64116, member FINRA/SiPC. Services involving securities shall be performed by Burch. Skytale Group and Burch are unaffiliated entities.
Learn more at skytalegroup.com.
SOURCE Skytale Group
link
More Stories
Symposium on International Investment Law & Contemporary Crises: Do Investment Treaties Accord Too Much (or Too Little) Protection to Banking and Finance Investments?
PrimeRx Has Been Acquired by RedSail Transaction
Breaking Barriers: How Two WashU Scholar-Champions are Revolutionizing Investment Banking Recruitment with AI